Placebo lactose powder

DIETARY_SUPPLEMENT2 trials

Sponsors

Tameside Hospital NHS Foundation Trust, Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic ObstructiveType 2 Diabetes

Phase 2

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02175342

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1998-03-01Updated: 2025-01-31

Phase 4

Effect of Arginine on Microcirculation in Patients With Diabetes

CompletedNCT00902616

Tameside Hospital NHS Foundation TrustType 2 Diabetes

Start: 2003-06-30End: 2006-06-30Updated: 2013-11-27